doi:10.3390/ijms19071987 8
Eli Lillys tirzepatide (Mounjaro and Zepbound) is a GIP (glucose-dependent insulinotropic polypeptide)/GLP-1 dual agonist that is demonstrating excellent weight loss, type 2 diabetes management, as well as cardiovascular protection
There is no reason not to have them more regularly
Noom Vibe combines incentive with self-efficacy to drive the adoption of healthy habits, while also encouraging community via expert talks and social connections with like-minded people
And because we know your time is valuable, you can choose in-office or virtual follow-up visits with bloodwork options at our clinic or partner LabCorp locations
Improved Metabolic Markers (Blood Sugar, Lipids, Liver Health) Early studies suggest GLP-1 microdosing may still improve insulin sensitivity, blood sugar regulation, lipid profiles, and liver function markers, even at subtherapeutic doses